{
    "status": "VOR", 
    "article-type": "discussion", 
    "contributors": [
        {
            "surname": "Bourne", 
            "corresp": "yes", 
            "affiliations": [
                {
                    "dept": "Department of Cellular and Molecular Pharmacology", 
                    "country": "United States", 
                    "institution": "University of California at San Francisco", 
                    "city": "San Francisco"
                }
            ], 
            "given-names": "Henry R", 
            "references": {
                "affiliation": [
                    "aff1"
                ], 
                "competing-interest": [
                    "conf1"
                ]
            }, 
            "type": "author", 
            "id": "author-4370"
        }
    ], 
    "pub-date": "2013-07-16", 
    "title": "A recipe for mediocrity and disaster, in five axioms", 
    "citations": [
        {
            "bib3": {
                "source": "Nature", 
                "doi": "10.1038/489203a", 
                "year": "2012", 
                "title": "Well-funded investigators should receive extra scrutiny", 
                "authors": [
                    {
                        "group-type": "author", 
                        "given-names": "JM", 
                        "surname": "Berg"
                    }
                ]
            }
        }, 
        {
            "bib1": {
                "source": "eLife", 
                "doi": "10.7554/eLife.00642", 
                "year": "2013", 
                "title": "The writing on the wall", 
                "authors": [
                    {
                        "group-type": "author", 
                        "given-names": "HR", 
                        "surname": "Bourne"
                    }
                ]
            }
        }, 
        {
            "bib4": {
                "source": "PLOS ONE", 
                "doi": "10.1371/journal.pone.0065263", 
                "year": "2013", 
                "title": "Big science vs. little science: how scientific impact scales with funding", 
                "authors": [
                    {
                        "group-type": "author", 
                        "given-names": "J-M", 
                        "surname": "Fortin"
                    }, 
                    {
                        "group-type": "author", 
                        "given-names": "DJ", 
                        "surname": "Currie"
                    }
                ]
            }
        }, 
        {
            "bib2": {
                "source": "Neuron", 
                "doi": "10.1016/j.neuron.2009.09.022", 
                "year": "2009", 
                "title": "The way biomedical research is organized has dramatically changed over the past half-century: are the changes for the better?", 
                "authors": [
                    {
                        "group-type": "author", 
                        "given-names": "DH", 
                        "surname": "Hubel"
                    }
                ]
            }
        }, 
        {
            "bib5": {
                "source": "Science", 
                "doi": "10.1126/science.340.6139.1394", 
                "year": "2013", 
                "title": "How long can the US stay on top?", 
                "authors": [
                    {
                        "group-type": "author", 
                        "given-names": "J", 
                        "surname": "Mervis"
                    }
                ]
            }
        }
    ], 
    "impact-statement": "", 
    "related-articles": [], 
    "elocation-id": "e01138", 
    "publish": "1", 
    "article-version-id": "01138.1", 
    "volume": "2", 
    "keywords": {
        "author-keywords": [
            "point of view", 
            "science policy and funding", 
            "careers in science", 
            "NIH", 
            "postdocs", 
            "grad school"
        ]
    }, 
    "doi": "10.7554/eLife.01138", 
    "version": "1", 
    "referenced": {
        "present-address": {}, 
        "competing-interest": {
            "conf1": "The author declares that no competing interests exist."
        }, 
        "funding": null, 
        "related-object": {}, 
        "foot-note": {}, 
        "affiliation": [
            {
                "aff1": {
                    "dept": "Department of Cellular and Molecular Pharmacology", 
                    "email": "henry.bourne@ucsf.edu", 
                    "city": "San Francisco", 
                    "institution": "University of California at San Francisco", 
                    "country": "United States"
                }
            }
        ], 
        "equal-contrib": {}, 
        "contribution": {}, 
        "email": {}
    }, 
    "path": "content/2/e01138v1", 
    "fragments": [], 
    "article-id": "01138", 
    "categories": {
        "sub-display-channel": [
            "Point of view"
        ], 
        "display-channel": [
            "Feature article"
        ]
    }
}
